van Houte Hans
Chief Financial Officer
CIK: 1817217
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Nurix Therapeutics, Inc. (NRIX) | A | 42,875 | $0.00 | $0.00 | View Details Filing |
| Feb 10, 2026 | Nurix Therapeutics, Inc. (NRIX) | A | 93,750 | $0.00 | $0.00 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | M | 2,859 | $0.00 | $0.00 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | M | 2,000 | $0.00 | $0.00 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | M | 3,750 | $0.00 | $0.00 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | S | 3,588 | $16.58 | $59,498.37 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | M | 2,887 | $0.00 | $0.00 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | M | 2,000 | $0.00 | $0.00 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | M | 2,859 | $0.00 | $0.00 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | M | 2,887 | $0.00 | $0.00 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | S | 73 | $17.37 | $1,268.13 | View Details Filing |
| Jan 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | M | 3,750 | $0.00 | $0.00 | View Details Filing |